226 related articles for article (PubMed ID: 20869952)
21. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
[TBL] [Abstract][Full Text] [Related]
22. The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.
Cavigiolio G; Shao B; Geier EG; Ren G; Heinecke JW; Oda MN
Biochemistry; 2008 Apr; 47(16):4770-9. PubMed ID: 18366184
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.
Wong-Mauldin K; Raussens V; Forte TM; Ryan RO
J Biol Chem; 2009 Nov; 284(48):33369-76. PubMed ID: 19825998
[TBL] [Abstract][Full Text] [Related]
24. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of reconstituted high density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDL.
Cho KH
Mol Cells; 2009 Mar; 27(3):291-7. PubMed ID: 19326075
[TBL] [Abstract][Full Text] [Related]
26. A zebrafish model for the rapid evaluation of pro-oxidative and inflammatory death by lipopolysaccharide, oxidized low-density lipoproteins, and glycated high-density lipoproteins.
Park KH; Cho KH
Fish Shellfish Immunol; 2011 Dec; 31(6):904-10. PubMed ID: 21906681
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of the remodeling of high density lipoproteins by phospholipid transfer protein.
Settasatian N; Duong M; Curtiss LK; Ehnholm C; Jauhiainen M; Huuskonen J; Rye KA
J Biol Chem; 2001 Jul; 276(29):26898-905. PubMed ID: 11325961
[TBL] [Abstract][Full Text] [Related]
28. Structural and Functional Impairments of Reconstituted High-Density Lipoprotein by Incorporation of Recombinant β-Amyloid42.
Cho KH
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299592
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
[TBL] [Abstract][Full Text] [Related]
30. Structure of apolipoprotein A-I in three homogeneous, reconstituted high density lipoprotein particles.
Wald JH; Krul ES; Jonas A
J Biol Chem; 1990 Nov; 265(32):20037-43. PubMed ID: 2123198
[TBL] [Abstract][Full Text] [Related]
31. Synergistic Anti-Inflammatory Activity of Lipid-Free Apolipoprotein (apo) A-I and CIGB-258 in Acute-Phase Zebrafish via Stabilization of the apoA-I Structure to Enhance Anti-Glycation and Antioxidant Activities.
Cho KH; Bahuguna A; Lee Y; Lee SH; Dominguez-Horta MDC; Martinez-Donato G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791598
[TBL] [Abstract][Full Text] [Related]
32. Human Serum Amyloid a Impaired Structural Stability of High-Density Lipoproteins (HDL) and Apolipoprotein (Apo) A-I and Exacerbated Glycation Susceptibility of ApoA-I and HDL.
Cho KH
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807498
[TBL] [Abstract][Full Text] [Related]
33. Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure.
Courtney HS; Zhang YM; Frank MW; Rock CO
J Biol Chem; 2006 Mar; 281(9):5515-21. PubMed ID: 16407233
[TBL] [Abstract][Full Text] [Related]
34. ApoA-I mutants V156K and R173C promote anti-inflammatory function and antioxidant activities.
Cho KH; Park SH; Han JM; Kim HC; Choi YK; Choi I
Eur J Clin Invest; 2006 Dec; 36(12):875-82. PubMed ID: 17087782
[TBL] [Abstract][Full Text] [Related]
35. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
36. A point mutant of apolipoprotein A-I, V156K, exhibited potent anti-oxidant and anti-atherosclerotic activity in hypercholesterolemic C57BL/6 mice.
Cho KH; Park SH; Han JM; Kim HC; Chung YJ; Choi I; Kim JR
Exp Mol Med; 2007 Apr; 39(2):160-9. PubMed ID: 17464177
[TBL] [Abstract][Full Text] [Related]
37. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis.
Beckstead JA; Oda MN; Martin DD; Forte TM; Bielicki JK; Berger T; Luty R; Kay CM; Ryan RO
Biochemistry; 2003 Aug; 42(31):9416-23. PubMed ID: 12899628
[TBL] [Abstract][Full Text] [Related]
38. Structure of apolipoprotein A-I N terminus on nascent high density lipoproteins.
Lagerstedt JO; Cavigiolio G; Budamagunta MS; Pagani I; Voss JC; Oda MN
J Biol Chem; 2011 Jan; 286(4):2966-75. PubMed ID: 21047795
[TBL] [Abstract][Full Text] [Related]
39. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
40. Synergistic Anti-Inflammatory Activity of Apolipoprotein A-I and CIGB-258 in Reconstituted High-Density Lipoproteins (rHDL) against Acute Toxicity of Carboxymethyllysine in Zebrafish and Its Embryo.
Cho KH; Kim JE; Kang DJ; Dominguez-Horta MDC; Martinez-Donato G
Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
